Komiya I, Nishio M, Murata S, Chiba F, Sakurai T, Shinkai S, Fujita M
J Pharmacobiodyn. 1984 Aug;7(8):545-55. doi: 10.1248/bpb1978.7.545.
A novel method was proposed to predict the elimination half-lives of cephalosporins from plasma protein binding (unbound fraction, f) and fraction of the dose excreted into urine (f*) on the basis of the following four assumptions. 1) The drug is only distributed to the extracellular fluid, 2) the bound fraction of the drug in plasma is independent of the plasma drug concentration, 3) the binding protein of the drug is albumin, 4) the unbound drug in plasma is excreted by the glomerular filtration and the contribution of active secretion and reabsorption is negligible. The VSS's and t1/2 beta's of MT-141, one of cephalosporins, in rabbits, dogs and healthy human subjects were well predicted, whereas in rats, the prediction of the both values was failed. The t1/2 beta's of various cephalosporins in healthy subjects were calculated from f and f*, in reasonably good agreement with the observed ones, except for some cephalosporins which have been reported to be secreted actively in the renal tubules. Thus, the comparison of the calculated t1/2 beta's with the observed ones makes it possible to presume the renal excretion mechanism. Moreover, this method will be applicable to other drugs which satisfy the above four assumptions.
基于以下四个假设,提出了一种新方法来根据血浆蛋白结合率(未结合分数,f)和经尿液排泄的剂量分数(f*)预测头孢菌素的消除半衰期。1)药物仅分布于细胞外液;2)药物在血浆中的结合分数与血浆药物浓度无关;3)药物的结合蛋白为白蛋白;4)血浆中的未结合药物通过肾小球滤过排泄,主动分泌和重吸收的贡献可忽略不计。对头孢菌素之一的MT - 141在兔、犬和健康人体受试者中的稳态分布容积(VSS)和β消除半衰期(t1/2β)进行了很好的预测,而在大鼠中,这两个值的预测均失败。根据f和f*计算了健康受试者中各种头孢菌素的t1/2β,除了一些已报道在肾小管中存在主动分泌的头孢菌素外,计算值与观察值相当吻合。因此,将计算得到的t1/2β与观察值进行比较,可以推测肾脏排泄机制。此外,该方法将适用于满足上述四个假设的其他药物。